Literature DB >> 35103157

Group B Streptococcus Bacteremia and Endocarditis in a Middle-Aged Male.

Johnny M McKenzie1, Lauren Pacheco1.   

Abstract

Group B Streptococcus (GBS) is a rare but increasingly recognized cause of invasive disease in nonpregnant adults, particularly in the United States. Invasive GBS can take on many forms and may involve virtually any organ system. This case report describes the presentation, diagnosis, and management of a middle-aged male with GBS bacteremia and endocarditis. A 59-year-old Caucasian male with a history of a heart murmur presented to the emergency department (ED) with two weeks of intermittent fevers, chills, rigors, and back pain. He had also become increasingly agitated and confused over this time. His heart murmur was discovered years prior during a work physical examination but was not investigated further. On arrival, he was afebrile but hypotensive and tachycardic. Physical examination revealed petechiae at the bilateral inferior palpebral conjunctivae as well as a grade 2 holosystolic murmur heard best at the apex. Abnormal laboratory findings included leukocytosis, transaminitis, elevated ferritin, and elevated D-dimer. Blood cultures were positive for Streptococcus agalactiae, and echocardiography demonstrated large mitral valve vegetations. The patient received intravenous (IV) antibiotics and eventually underwent a successful mitral valve replacement with a 31-mm pericardial tissue valve. No source of infection was identified in this patient despite an extensive workup. The incidence of invasive GBS among nonpregnant adults has increased significantly in recent decades. The majority of affected patients are elderly and with significant underlying medical conditions. GBS bacteremia and endocarditis carry a very high mortality rate despite appropriate antimicrobial therapy. Combined medical-surgical therapy confers better outcomes in cases of endocarditis. Our patient's history of a heart murmur could have represented previously undiagnosed mitral valve pathology, placing him at higher risk of endocarditis. Apart from that, however, he lacked most of the typical risk factors associated with invasive GBS infections. Otherwise healthy patients with invasive GBS should undergo a comprehensive workup for potential underlying chronic illnesses. In the proper clinical context, conjunctival petechiae should elicit concern for infective endocarditis as they are present at a rate similar to that of Janeway lesions, splinter hemorrhages, and Roth spots.
Copyright © 2021, McKenzie et al.

Entities:  

Keywords:  conjunctival petechiae; group b streptococcus (gbs); group b streptococcus agalactiae bacteremia; infective endocarditis ; mitral valve disease; streptococcal bacteremia; valvular vegetation

Year:  2021        PMID: 35103157      PMCID: PMC8776522          DOI: 10.7759/cureus.20578

Source DB:  PubMed          Journal:  Cureus        ISSN: 2168-8184


  11 in total

1.  Changing epidemiology of group B streptococcal infections among adults in Iceland: 1975-2014.

Authors:  E S Björnsdóttir; E R Martins; H Erlendsdóttir; G Haraldsson; J Melo-Cristino; K G Kristinsson; M Ramirez
Journal:  Clin Microbiol Infect       Date:  2015-12-12       Impact factor: 8.067

Review 2.  Clinical practice. Infective endocarditis.

Authors:  Bruno Hoen; Xavier Duval
Journal:  N Engl J Med       Date:  2013-04-11       Impact factor: 91.245

3.  Invasive group B streptococcal disease in Maryland nursing home residents.

Authors:  K J Henning; E L Hall; D M Dwyer; L Billmann; A Schuchat; J A Johnson; L H Harrison
Journal:  J Infect Dis       Date:  2001-03-01       Impact factor: 5.226

4.  Group B streptococcal disease in the era of intrapartum antibiotic prophylaxis.

Authors:  S J Schrag; S Zywicki; M M Farley; A L Reingold; L H Harrison; L B Lefkowitz; J L Hadler; R Danila; P R Cieslak; A Schuchat
Journal:  N Engl J Med       Date:  2000-01-06       Impact factor: 91.245

5.  Epidemiology of Invasive Group B Streptococcal Infections Among Nonpregnant Adults in the United States, 2008-2016.

Authors:  Louise K Francois Watkins; Lesley McGee; Stephanie J Schrag; Bernard Beall; Jennifer Hudson Jain; Tracy Pondo; Monica M Farley; Lee H Harrison; Shelley M Zansky; Joan Baumbach; Ruth Lynfield; Paula Snippes Vagnone; Lisa A Miller; William Schaffner; Ann R Thomas; James P Watt; Susan Petit; Gayle E Langley
Journal:  JAMA Intern Med       Date:  2019-04-01       Impact factor: 21.873

6.  Clinical profile of Streptococcus agalactiae native valve endocarditis.

Authors:  María Jesús Rollán; José Alberto San Román; Isidre Vilacosta; Cristina Sarriá; Javier López; María Acuña; José Luis Bratos
Journal:  Am Heart J       Date:  2003-12       Impact factor: 4.749

7.  Streptococcus agalactiae (group B) endocarditis--a description of twelve cases and review of the literature.

Authors:  B E Scully; D Spriggs; H C Neu
Journal:  Infection       Date:  1987 May-Jun       Impact factor: 3.553

8.  Invasive group B streptococcal disease in adults. A population-based study in metropolitan Atlanta.

Authors:  B Schwartz; A Schuchat; M J Oxtoby; S L Cochi; A Hightower; C V Broome
Journal:  JAMA       Date:  1991-08-28       Impact factor: 56.272

9.  Risk factors for group B streptococcal disease in adults.

Authors:  L A Jackson; R Hilsdon; M M Farley; L H Harrison; A L Reingold; B D Plikaytis; J D Wenger; A Schuchat
Journal:  Ann Intern Med       Date:  1995-09-15       Impact factor: 25.391

10.  A population-based assessment of invasive disease due to group B Streptococcus in nonpregnant adults.

Authors:  M M Farley; R C Harvey; T Stull; J D Smith; A Schuchat; J D Wenger; D S Stephens
Journal:  N Engl J Med       Date:  1993-06-24       Impact factor: 91.245

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.